Found: 22
Select item for more details and to access through your institution.
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1328368
- By:
- Publication type:
- Article
GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD<sub>2</sub> and Releasing Inducible IL-18.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.839783
- By:
- Publication type:
- Article
Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02326
- By:
- Publication type:
- Article
Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial.
- Published in:
- European Heart Journal, 2009, v. 30, n. 24, p. 2978, doi. 10.1093/eurheartj/ehp374
- By:
- Publication type:
- Article
A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. 7, p. 1221, doi. 10.1002/(SICI)1097-0142(19971001)80:7<1221::AID-CNCR4>3.0.CO;2-N
- By:
- Publication type:
- Article
Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® Platform.
- Published in:
- Transfusion Medicine & Hemotherapy, 2019, v. 46, n. 1, p. 47, doi. 10.1159/000495772
- By:
- Publication type:
- Article
Extracorporeal immune cell therapy of sepsis: ex vivo results.
- Published in:
- Intensive Care Medicine Experimental, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40635-022-00453-8
- By:
- Publication type:
- Article
Advantages and applications of CAR-expressing natural killer cells.
- Published in:
- Frontiers in Pharmacology, 2015, v. 6, p. 1, doi. 10.3389/fphar.2015.00021
- By:
- Publication type:
- Article
Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01100
- By:
- Publication type:
- Article
Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms.
- Published in:
- Frontiers in Immunology, 2016, v. 7, p. 1, doi. 10.3389/fimmu.2016.00393
- By:
- Publication type:
- Article
Intravitreal autologous bone-marrow-derived mononuclear cell transplantation.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report.
- Published in:
- Acta Ophthalmologica (1755375X), 2008, v. 86, n. 2, p. 225, doi. 10.1111/j.1600-0420.2007.00987.x
- By:
- Publication type:
- Article
Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMPcompliant manufacturing of antiviral T cells.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 139, doi. 10.1186/s12967-014-0336-5
- By:
- Publication type:
- Article
Adenosine stress perfusion cardiac magnetic resonance imaging in patients undergoing intracoronary bone marrow cell transfer after ST-elevation myocardial infarction: the BOOST-2 perfusion substudy.
- Published in:
- Clinical Research in Cardiology, 2020, v. 109, n. 5, p. 539, doi. 10.1007/s00392-019-01537-4
- By:
- Publication type:
- Article
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1328368
- By:
- Publication type:
- Article
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1328368
- By:
- Publication type:
- Article
Intracoronary autologous bonemarrow cell transfer aftermyocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
- Published in:
- European Heart Journal, 2017, v. 38, n. 39, p. 2936, doi. 10.1093/eurheartj/ehx188
- By:
- Publication type:
- Article
Extrinsic apoptotic pathways: a new potential 'target' for more sufficient therapy in a case of cutaneous anaplastic large CD30+ alk. T-cell lymphoma.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
EXTRINSIC APOPTOTIC PATHWAYS: A NEW POTENTIAL "TARGET" FOR MORE SUFFICIENT THERAPY IN A CASE OF CUTANEOUS ANAPLASTIC LARGE CD30+ ALK. T-CELL LYMPHOMA.
- Published in:
- Indian Journal of Dermatology, 2011, v. 56, n. 1, p. 87, doi. 10.4103/0019-5154.77563
- By:
- Publication type:
- Article
Cetuximab reconstitutes pro-inflammatory cytokine secretions and tumor-infiltrating capabilities of sMica-inhibited NK cells in HNSCC tumor spheroids.
- Published in:
- Frontiers in Immunology, 2015, v. 6, p. 1, doi. 10.3389/fimmu.2015.00543
- By:
- Publication type:
- Article
The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
- Published in:
- European Journal of Immunology, 1997, v. 27, n. 6, p. 1522, doi. 10.1002/eji.1830270631
- By:
- Publication type:
- Article
Sustained decrease of peripheral lymphocytes after allogeneic blood stem cell aphereses.
- Published in:
- British Journal of Haematology, 1998, v. 100, n. 4, p. 695, doi. 10.1046/j.1365-2141.1998.00629.x
- By:
- Publication type:
- Article